The US Food and Drug Administration (FDA) has directed weight loss drugs to bear warning labels about a potential risk of causing a rare eye complication or blindness called NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy). This includes drugs like Ozempic, Wegovy, Mounjaro, Zepbound and other GLP-1 medications used for treating diabetes and now obesity-related problems.As per reports, this disorder happens when the blood supply to the…